Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Epinephrine bitartrate by De Motu Cordis for Anaphylaxis: Likelihood of Approval
Epinephrine bitartrate is under clinical development by De Motu Cordis and currently in Phase I for Anaphylaxis. According to GlobalData,...